Atul’s 100% subsidiary -- Atul Bioscience (ABL) has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility situated in Ambernath, Maharashtra. The EIR was issued post the last inspection of the facility conducted from May 06, 2024, to May 10, 2024 which concluded with zero FDA 483 observations.
Atul is one of the largest integrated chemical companies of India. The company has one of the biggest integrated chemical complexes in India with a well-diversified product portfolio of around products and formulations.
